136 related articles for article (PubMed ID: 21263198)
1. Thyroid hormone therapy modulates hypothalamo-pituitary-adrenal axis.
Lizcano F; Rodríguez JS
Endocr J; 2011; 58(2):137-42. PubMed ID: 21263198
[TBL] [Abstract][Full Text] [Related]
2. Effects of different treatments for hyperthyroidism on the hypothalamic-pituitary-adrenal axis.
Lizcano F; Salvador J
Clin Exp Pharmacol Physiol; 2008 Sep; 35(9):1085-90. PubMed ID: 18505442
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of hypothalamo-pituitary-adrenocortical function in children by human corticotropin-releasing hormone (MCI-028) test.
Tanaka T; Hibi I; Shimizu N; Imura H; Tanaka K; Fukata J; Fujieda K; Ichimura T; Kuribayashi T; Ito K
Endocr J; 1993 Oct; 40(5):581-9. PubMed ID: 7951524
[TBL] [Abstract][Full Text] [Related]
4. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
[TBL] [Abstract][Full Text] [Related]
5. Recovery from glucocorticoid inhibition of the responses to corticotrophin-releasing hormone.
Watson AC; Rosenfield RL; Fang VS
Clin Endocrinol (Oxf); 1988 May; 28(5):471-7. PubMed ID: 2850875
[TBL] [Abstract][Full Text] [Related]
6. Effect of acute and prolonged mineralocorticoid receptor blockade on spontaneous and stimulated hypothalamic-pituitary-adrenal axis in humans.
Berardelli R; Karamouzis I; Marinazzo E; Prats E; Picu A; Giordano R; Ghigo E; Arvat E
Eur J Endocrinol; 2010 Jun; 162(6):1067-74. PubMed ID: 20219855
[TBL] [Abstract][Full Text] [Related]
7. Assessment of stimulated and spontaneous adrenocorticotropin secretory dynamics identifies distinct components of cortisol feedback inhibition in healthy humans.
Dorin RI; Ferries LM; Roberts B; Qualls CR; Veldhuis JD; Lisansky EJ
J Clin Endocrinol Metab; 1996 Nov; 81(11):3883-91. PubMed ID: 8923833
[TBL] [Abstract][Full Text] [Related]
8. Classification of polycystic ovary syndrome into three types according to response to human corticotropin-releasing hormone.
Kondoh Y; Uemura T; Ishikawa M; Yokoi N; Hirahara F
Fertil Steril; 1999 Jul; 72(1):15-20. PubMed ID: 10428142
[TBL] [Abstract][Full Text] [Related]
9. Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment.
Kudielka BM; Schmidt-Reinwald AK; Hellhammer DH; Kirschbaum C
Neuroendocrinology; 1999 Dec; 70(6):422-30. PubMed ID: 10657735
[TBL] [Abstract][Full Text] [Related]
10. Effect of altered thyroid hormone levels on hypothalamic-pituitary-adrenal function.
Kamilaris TC; DeBold CR; Pavlou SN; Island DP; Hoursanidis A; Orth DN
J Clin Endocrinol Metab; 1987 Nov; 65(5):994-9. PubMed ID: 3499449
[TBL] [Abstract][Full Text] [Related]
11. Adrenocorticotropic hormone and cortisol concentrations after corticotropin-releasing hormone stimulation testing in cats administered methylprednisolone.
Crager CS; Dillon AR; Kemppainen RJ; Brewer WG; Angarano DW
Am J Vet Res; 1994 May; 55(5):704-9. PubMed ID: 8067621
[TBL] [Abstract][Full Text] [Related]
12. Gonadotropin-releasing hormone agonist in premenopausal women does not alter hypothalamic-pituitary-adrenal axis response to corticotropin-releasing hormone.
Gavin KM; Shea KL; Gibbons E; Wolfe P; Schwartz RS; Wierman ME; Kohrt WM
Am J Physiol Endocrinol Metab; 2018 Aug; 315(2):E316-E325. PubMed ID: 29631362
[TBL] [Abstract][Full Text] [Related]
13. A comparison of the naloxone test with ovine CRH and insulin hypoglycaemia in the evaluation of the hypothalamic-pituitary-adrenal axis in normal man.
Inder WJ; Ellis MJ; Evans MJ; Donald RA
Clin Endocrinol (Oxf); 1995 Oct; 43(4):425-31. PubMed ID: 7586616
[TBL] [Abstract][Full Text] [Related]
14. Corticotropin and cortisol response to human CRH as a probe for HPA system integrity in major depressive disorder.
Lesch KP; Laux G; Schulte HM; Pfüller H; Beckmann H
Psychiatry Res; 1988 Apr; 24(1):25-34. PubMed ID: 2839859
[TBL] [Abstract][Full Text] [Related]
15. The combined dexamethasone-suppression/CRH-stimulation test in alcoholics during and after acute withdrawal.
Hundt W; Zimmermann U; Pöttig M; Spring K; Holsboer F
Alcohol Clin Exp Res; 2001 May; 25(5):687-91. PubMed ID: 11371718
[TBL] [Abstract][Full Text] [Related]
16. Hypothalamo-pituitary-adrenal axis dysfunction in chronic fatigue syndrome, and the effects of low-dose hydrocortisone therapy.
Cleare AJ; Miell J; Heap E; Sookdeo S; Young L; Malhi GS; O'Keane V
J Clin Endocrinol Metab; 2001 Aug; 86(8):3545-54. PubMed ID: 11502777
[TBL] [Abstract][Full Text] [Related]
17. Thyroid Hormone Deficiency Suppresses Fetal Pituitary-Adrenal Function Near Term: Implications for the Control of Fetal Maturation and Parturition.
Camm EJ; Inzani I; De Blasio MJ; Davies KL; Lloyd IR; Wooding FBP; Blache D; Fowden AL; Forhead AJ
Thyroid; 2021 Jun; 31(6):861-869. PubMed ID: 33126831
[No Abstract] [Full Text] [Related]
18. Evaluation of corticotropin releasing factor stimulation and basal markers of hypothalamic-pituitary-adrenal axis suppression in asthmatic patients.
Clark DJ; Lipworth BJ
Chest; 1997 Nov; 112(5):1248-52. PubMed ID: 9367464
[TBL] [Abstract][Full Text] [Related]
19. Somatostatin treatment reduces the exaggerated response of adrenocorticotropin hormone and cortisol to corticotropin-releasing hormone in polycystic ovary syndrome.
Lanzone A; Fulghesu AM; Guido M; Cucinelli F; Caruso A; Mancuso S
Fertil Steril; 1997 Jan; 67(1):34-9. PubMed ID: 8986680
[TBL] [Abstract][Full Text] [Related]
20. Human corticotropin-releasing hormone test in patients with hypothalamo-pituitary-adrenocortical disorders.
Fukata J; Shimizu N; Imura H; Hibi I; Tanaka K; Tanaka T; Nakagawa S; Takebe K; Kimura K; Yoshinaga K
Endocr J; 1993 Oct; 40(5):597-606. PubMed ID: 7951526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
